These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 3460737)

  • 1. The effect of food on the pharmacokinetics of ofloxacin.
    Verho M; Malerczyk V; Dagrosa E; Korn A
    Curr Med Res Opin; 1986; 10(3):166-71. PubMed ID: 3460737
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dose linearity and other pharmacokinetics of ofloxacin: a new, broad-spectrum antimicrobial agent.
    Verho M; Malerczyk V; Dagrosa E; Korn A
    Pharmatherapeutica; 1985; 4(6):376-82. PubMed ID: 3866256
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multiple-dose pharmacokinetics of ofloxacin, a new broad-spectrum antimicrobial agent.
    Dagrosa EE; Verho M; Malerczyk V; de Looze S; Hajdú P; Toyodera K
    Clin Ther; 1986; 8(6):632-45. PubMed ID: 3466701
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relative bioavailability of ofloxacin tablets in comparison to oral solution.
    Malerczyk V; Verho M; Korn A; Rangoonwala R
    Curr Med Res Opin; 1987; 10(8):514-20. PubMed ID: 3479296
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics of a single oral dose of ofloxacin in patients with renal failure.
    Nawishy S; Moukhtar I; Sabbour M
    Chemioterapia; 1986 Dec; 5(6):391-3. PubMed ID: 3467875
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The pharmacokinetics and tissue penetration of ofloxacin.
    Lockley MR; Wise R; Dent J
    J Antimicrob Chemother; 1984 Dec; 14(6):647-52. PubMed ID: 6596301
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The comparative pharmacokinetics and tissue penetration of four quinolones including intravenously administered enoxacin.
    Wise R; Lister D; McNulty CA; Griggs D; Andrews JM
    Infection; 1986; 14 Suppl 3():S196-202. PubMed ID: 3463542
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ofloxacin: serum and skin blister fluid pharmacokinetics in the fasting and non-fasting state.
    Kalager T; Digranes A; Bergan T; Rolstad T
    J Antimicrob Chemother; 1986 Jun; 17(6):795-800. PubMed ID: 3460984
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics of levofloxacin in comparison to the racemic mixture of ofloxacin in man.
    Verho M; Malerczyk V; Damm D; Lehr KH
    Drug Metabol Drug Interact; 1996; 13(1):57-67. PubMed ID: 8902431
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dose linearity testing of intravenous ofloxacin, a novel gyrase inhibitor.
    Verho M; Korn A; Badian M; Malerczyk V; Waldhäusl W
    Chemotherapy; 1988; 34(3):170-7. PubMed ID: 3166420
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics of ofloxacin and theophylline alone and in combination.
    Fourtillan JB; Granier J; Saint-Salvi B; Salmon J; Surjus A; Tremblay D; Vincent Du Laurier M; Beck S
    Infection; 1986; 14 Suppl 1():S67-9. PubMed ID: 3456985
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Pharmacokinetics of ofloxacin in the elderly (65-85 years) with normal renal function after a single oral dose of 200 mg].
    Veyssier P; Fourtillan JB; Modai J; Couet W; Lefebvre MA; Darchis JP; Vincent Du Laurier M; Bryskier A
    Pathol Biol (Paris); 1986 Jun; 34(5 Pt 2):596-9. PubMed ID: 3534750
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Intracamera penetration of ofloxacin in man].
    Bron A; Talon D; Delbosc B; Estavoyer JM; Kaya G; Royer J
    J Fr Ophtalmol; 1987; 10(6-7):443-6. PubMed ID: 3500972
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The clinical pharmacokinetics of levofloxacin.
    Fish DN; Chow AT
    Clin Pharmacokinet; 1997 Feb; 32(2):101-19. PubMed ID: 9068926
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics of levofloxacin in healthy Thai male volunteers.
    Chulavatnatol S; Chindavijak B; Vibhagool A; Wananukul W; Sriapha C; Sirisangtragul C
    J Med Assoc Thai; 1999 Nov; 82(11):1127-35. PubMed ID: 10659548
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dose related pharmacokinetics of ofloxacin in healthy volunteers.
    Immanuel C; Hemanthkumar AK; Gurumurthy P; Venkatesan P
    Int J Tuberc Lung Dis; 2002 Nov; 6(11):1017-22. PubMed ID: 12475149
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A preliminary report on the pharmacokinetics of ofloxacin, desmethyl ofloxacin and ofloxacin N-oxide in patients with chronic renal failure.
    White LO; MacGowan AP; Lovering AM; Reeves DS; Mackay IG
    Drugs; 1987; 34 Suppl 1():56-61. PubMed ID: 3481329
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Diffusion of an orally administered single dose of ofloxacin into human bronchial mucus].
    Morel C; Malbruny B; Vergnaud M; Benard Y; Monrocq N
    Pathol Biol (Paris); 1986 May; 34(5):353-6. PubMed ID: 3534705
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of food on the pharmacokinetics of a single oral dose of moxifloxacin 400mg in healthy male volunteers.
    Lettieri J; Vargas R; Agarwal V; Liu P
    Clin Pharmacokinet; 2001; 40 Suppl 1():19-25. PubMed ID: 11352438
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of food on cabergoline pharmacokinetics and tolerability in healthy volunteers.
    Persiani S; Rocchetti M; Pacciarini MA; Holt B; Toon S; Strolin-Benedetti M
    Biopharm Drug Dispos; 1996 Jul; 17(5):443-55. PubMed ID: 8830979
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.